DePuy Orthopedics, along with their parent company, Johnson & Johnson, issued a recall of their ASR XL Acetabular Hip System, along with the ASR Hip Resurfacing System in August of 2010. This recall was implemented following a flurry of adverse event reports among recipients of one of these two hip implants. At the time of the recall DePuy and Johnson and Johnson acknowledged that the ASR XL and the ASR Hip Resurfacing System had a higher-than-expected rate of failure—as much as 12% within a short time after implantation. At the time of the recall, DePuy stated that the ASR could loosen or misalign and that recipients of the ASR were at a higher risk for infection, bone fracture, dislocation, metallosis, metal toxicity and pain.